{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:52:12Z","timestamp":1758473532508},"reference-count":0,"publisher":"MDPI AG","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Pharm."],"published-print":{"date-parts":[[2013]]},"DOI":"10.3797\/scipharm.1209-10","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T20:52:20Z","timestamp":1375131140000},"page":"855-864","source":"Crossref","is-referenced-by-count":2,"title":["Evidence of Polymorphism on the Antitrypanosomal Naphthoquinone (4E)-2-(1H-Pyrazol-3-ylamino)-4-(1H-pyrazol-3-ylimino)naphthalen-1(4H)-one"],"prefix":"10.3390","volume":"81","author":[{"given":"Norma R.","family":"Sperandeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","container-title":["Scientia Pharmaceutica"],"original-title":[],"deposited":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T13:06:26Z","timestamp":1500383186000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mdpi.com\/2218-0532\/81\/3\/855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3797\/scipharm.1209-10","relation":{},"ISSN":["0036-8709","2218-0532"],"issn-type":[{"value":"0036-8709","type":"print"},{"value":"2218-0532","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}